Abstract
Host pattern recognition receptors (PRRs) recognize invading viral pathogens and initiate a series of signaling cascades that lead to the expression of type I interferons (IFNs) and inflammatory cytokines. During the past decade, significant progresses have been made to characterize PRRs such as Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs) and elucidate the molecular mechanisms of TLR- and RLR-mediated signaling. To avoid excessive and harmful immune effects caused by over-activation of these signaling pathways, host cells adopt a number of strategies to regulate them. In addition, invading viruses also employ a variety of mechanisms to inhibit the production of type I IFNs, thereby evading the supervision and clearance by the host. In this review, we briefly summarize the TLR- and RLR-mediated type I IFN signaling and then focus on the mechanisms by which host cellular and viral components regulate the expression of type I IFNs.
Article PDF
Similar content being viewed by others
References
Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, Moriishi K, Takeuchi O, Kawai T, Kanto T, Hayashi N, Akira S, Matsuura Y (2007). Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J Virol, 81(17): 8953–8966
Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald K A, Hornung V (2009). RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol, 10(10): 1065–1072
Akira S, Takeda K (2004). Toll-like receptor signalling. Nat Rev Immunol, 4(7): 499–511
Akira S, Uematsu S, Takeuchi O (2006). Pathogen recognition and innate immunity. Cell, 124(4): 783–801
Alexopoulou L, Holt A C, Medzhitov R, Flavell R A (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature, 413(6857): 732–738
Alff P J, Gavrilovskaya I N, Gorbunova E, Endriss K, Chong Y, Geimonen E, Sen N, Reich N C, Mackow E R (2006). The Pathogenic NY-1 Hantavirus G1 Cytoplasmic Tail Inhibits RIG-I and TBK-1 Directed Interferon Responses. J Virol, 80(19): 9676–9686
An H, Hou J, Zhou J, Zhao W, Xu H, Zheng Y, Yu Y, Liu S, Cao X (2008). Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol, 9(5): 542–550
An H, Zhao W, Hou J, Zhang Y, Xie Y, Zheng Y, Xu H, Qian C, Zhou J, Yu Y, Liu S, Feng G, Cao X (2006). SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity, 25(6): 919–928
Andrejeva J, Childs K S, Young D F, Carlos T S, Stock N, Goodbourn S, Randall R E (2004). The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A, 101(49): 17264–17269
Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K (2007). Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A, 104(18): 7500–7505
Bachler C, Flukiger-Bruhwiler K, Schneider P, Bahler P, Erni B (2005). From ATP as substrate to ADP as coenzyme: functional evolution of the nucleotide binding subunit of dihydroxyacetone kinases. J Biol Chem, 280(18): 18321–18325
Bao X, Liu T, Shan Y, Li K, Garofalo R P, Casola A (2008). Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog, 4(5): e1000077
Barral P M, Morrison J M, Drahos J, Gupta P, Sarkar D, Fisher P B, Racaniello V R (2007). MDA-5 is cleaved in poliovirus-infected cells. J Virol, 81(8): 3677–3684
Barro M, Patton J T (2007). Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol, 81(9): 4473–4481
Bauhofer O, Summerfield A, Sakoda Y, Tratschin J D, Hofmann M A, Ruggli N (2007). Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol, 81(7): 3087–3096
Boone D L, Turer E E, Lee E G, Ahmad R C, Wheeler M T, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, McNally E, Pickart C, Ma A (2004). The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol, 5(10):1052–1060
Bowie A G, Unterholzner L (2008). Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol, 8(12):911–922
Bradley J R, Pober J S (2001). Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene, 20(44): 6482–6491
Bromberg K D, Kluger H M, Delaunay A, Abbas S, DiVito K A, Krajewski S, Ronai Z (2007). Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer. Cancer Res, 67(17): 8172–8179
Brzozka K, Finke S, Conzelmann K K (2005). Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol, 79(12): 7673–7681
Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J (2003). Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med, 197(2): 263–268
Cabezas A, Costas M J, Pinto R M, Couto A, Cameselle J C (2005). Identification of human and rat FAD-AMP lyase (cyclic FMN forming) as ATP-dependent dihydroxyacetone kinases. Biochem Biophys Res Commun, 338(4): 1682–1689s
Cardenas W B, Loo Y M, Gale M Jr, Hartman A L, Kimberlin C R, Martinez-Sobrido L, Saphire E O, Basler C F (2006). Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol, 80(11):5168–5178
Carty M, Goodbody R, Schroder M, Stack J, Moynagh P N, Bowie A G (2006). The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol, 7(10): 1074–1081
Chang HW, Watson J C, Jacobs B L (1992). Thsse E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A, 89(11):4825–4829
Chen R A, Ryzhakov G, Cooray S, Randow F, Smith G L (2008). Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog, 4(2): e22
Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, Guo D (2009). Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc Natl Acad Sci U S A, 106(9): 3484–3489
Chen Z, Benureau Y, Rijnbrand R, Yi J, Wang T, Warter L, Lanford R E, Weinman S A, Lemon S M, Martin A, Li K (2007). GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol, 81(2): 964–976
Chiu Y H, Macmillan J B, Chen Z J (2009). RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell, 138(3): 576–591
Chuang T H, Ulevitch R J (2004). Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol, 5(5): 495–502
Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, Lammens K, Fujita T, Conzelmann K K, Krug A, Hopfner K P (2008). The Cterminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol Cell, 29(2): 169–179
Cusson-Hermance N, Khurana S, Lee T H, Fitzgerald K A, Kelliher MA (2005). Rip1 mediates the Trif-dependent toll-like receptor 3- and 4- induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem, 280(44): 36560–36566
Delaunay A, Bromberg K D, Hayashi Y, Mirabella M, Burch D, Kirkwood B, Serra C, Malicdan M C, Mizisin A P, Morosetti R, Broccolini A, Guo L T, Jones S N, Lira S A, Puri P L, Shelton G D, Ronai Z (2008). The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS ONE, 3(2): e1609
Deng W, Shi M, Han M, Zhong J, Li Z, Li W, Hu Y, Yan L, Wang J, He Y, Tang H, Deubel V, Luo X, Ning Q, Sun B (2008). Negative regulation of virus-triggered IFN-beta signaling pathway by alternative splicing of TBK1. J Biol Chem, 283(51): 35590–35597
Devaraj S G, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, Lin R, Peters C J, Tseng C T, Baker S C, Li K (2007). Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem, 282(44): 32208–32221
Diao F, Li S, Tian Y, Zhang M, Xu L G, Zhang Y, Wang R P, Chen D, Zhai Z, Zhong B, Tien P, Shu H B (2007). Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci U S A, 104(28):11706–11711
Didier C, Broday L, Bhoumik A, Israeli S, Takahashi S, Nakayama K, Thomas S M, Turner C E, Henderson S, Sabe H, Ronai Z (2003). RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization. Mol Cell Biol, 23(15): 5331–5345
Diebold S S, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science, 303(5663): 1529–1531
DiPerna G, Stack J, Bowie A G, Boyd A, Kotwal G, Zhang Z, Arvikar S, Latz E, Fitzgerald K A, Marshall W L (2004). Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem, 279(35): 36570–36578
Ea C K, Deng L, Xia Z P, Pineda G, Chen Z J (2006). Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell, 22(2): 245–257
Edelmann K H, Richardson-Burns S, Alexopoulou L, Tyler K L, Flavell R A, Oldstone M B (2004). Does Toll-like receptor 3 play a biological role in virus infections? Virology, 322(2): 231–238
Flanegan J B, Petterson R F, Ambros V, Hewlett N J, Baltimore D (1977). Covalent linkage of a protein to a defined nucleotide sequence at the 5′-terminus of virion and replicative intermediate RNAs of poliovirus. Proc Natl Acad Sci U S A, 74(3): 961–965
Friedman C S, O’Donnell M A, Legarda-Addison D, Ng A, Cardenas W B, Yount J S, Moran T M, Basler C F, Komuro A, Horvath C M, Xavier R, Ting A T (2008). The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep, 9(9): 930–936
Furuichi Y, Furuichi A J (2000). Viral and cellular mRNA capping: past and prospects. Adv Virus Res, 55: 135–184
Gack M U, Kirchhofer A, Shin Y C, Inn K S, Liang C, Cui S, Myong S, Ha T, Hopfner K P, Jung J U (2008). Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci U S A, 105(43): 16743–16748
Gack M U, Shin Y C, Joo C H, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung J U (2007). TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature, 446(7138): 916–920
Gao D, Wang R, Li B, Yang Y, Zhai Z, Chen D Y (2009). WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappaB activation pathway. Cell Mol Life Sci, 66(15):2573–2584
Gao D, Yang Y K, Wang R P, Zhou X, Diao F C, Li M D, Zhai Z H, Jiang Z F, Chen D Y (2009). REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One, 4(6): e5760
Gatot J S, Gioia R, Chau T L, Patrascu F, Warnier M, Close P, Chapelle J P, Muraille E, Brown K, Siebenlist U, Piette J, Dejardin E, Chariot A (2007). Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J Biol Chem, 282(43): 31131–31146
Gohda J, Matsumura T, Inoue J (2004). Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J Immunol, 173(5):2913–2917
Guo B, Cheng G (2007). Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem, 282(16):11817–11826
Gutierrez M G, Master S S, Singh S B, Taylor G A, Colombo M I, Deretic V (2004). Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell, 119(6): 753–766
Haasnoot J, de Vries W, Geutjes E J, Prins M, de Haan P, Berkhout B (2007). The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog, 3(6): e86
Habjan M, Andersson I, Klingstrom J, Schumann M, Martin A, Zimmermann P, Wagner V, Pichlmair A, Schneider U, Muhlberger E, Mirazimi A, Weber F (2008). Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One, 3(4): e2032
Han K J, Su X, Xu L G, Bin L H, Zhang J, Shu H B (2004). Mechanisms of the TRIF-induced interferon-stimulated response element and NFkappaB activation and apoptosis pathways. J Biol Chem, 279(15):15652–15661
Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science, 303(5663); 1526–1529
Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S (2002). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol, 3(2): 196–200
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S (2000). A Toll-like receptor recognizes bacterial DNA. Nature, 408(6813): 740–745
Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, Akira S (2004). The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med, 199(12): 1641–1650
Higgs R, Ni Gabhann J, Ben Larbi N, Breen E P, Fitzgerald K A, Jefferies C A (2008). The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J Immunol, 181(3): 1780–1786
Honda K, Takaoka A, Taniguchi T (2006). Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity, 25(3): 349–360
Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh W C, Taniguchi T (2004). Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A, 101(43): 15416–15421
Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann K K, Schlee M, Endres S, Hartmann G (2006). 5′-Triphosphate RNA is the ligand for RIG-I. Science, 314(5801):994–997
Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G (2005). Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med, 11(3): 263–270
Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, Hemmi H, Ohara O, Akira S, Kaisho T (2006). IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature, 440(7086): 949–953
Hu X, Paik P K, Chen J, Yarilina A, Kockeritz L, Lu T T, Woodgett J R, Ivashkiv L B (2006). IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity, 24(5): 563–574
Huang J, Liu T, Xu L G, Chen D, Zhai Z, Shu H B (2005). SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virustriggered IRF-3 activation pathways. Embo J, 24(23): 4018–4028
Ishikawa H, Barber G N (2008). STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature, 455(7213):674–678
Ishikawa H, Ma Z, Barber G N (2009). STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature, 461(7265): 788–792
Jiang Z, Mak T W, Sen G, Li X (2004). Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci U S A, 101(10): 3533–3538
Joo C H, Shin Y C, Gack M, Wu L, Levy D, Jung J U (2007). Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi’s sarcoma-associated herpesvirus viral IRF homolog vIRF3. J Virol, 81(15): 8282–8292
Jounai N, Takeshita F, Kobiyama K, Sawano A, Miyawaki A, Xin K Q, Ishii K J, Kawai T, Akira S, Suzuki K, Okuda K (2007). The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci U S A, 104(35): 14050–14055
Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody T S, Fujita T, Akira S (2008). Length-dependent recognition of double-stranded ribonucleic acids by retinoic acidinducible gene-I and melanoma differentiation-associated gene 5. J Exp Med, 205(7): 1601–1610
Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii K J, Yamaguchi O, Otsu K, Tsujimura T, Koh C S, Reis e Sousa C, Matsuura Y, Fujita T, Akira S (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature, 441(7089): 101–105
Kawagoe T, Takeuchi O, Takabatake Y, Kato H, Isaka Y, Tsujimura T, Akira S (2009). TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol, 10(9): 965–972
Kawai T, Akira S (2008). Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci, 1143: 1–20
Kawai T, Akira S (2009). The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol, 21(4): 317–337
Kawai T, Sato S, Ishii K J, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O, Akira S (2004). Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol, 5(10): 1061–1068
Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii K J, Takeuchi O, Akira S (2005). IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol, 6(10):981–988
Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, O’Rourke K M, Eby M, Pietras E, Cheng G, Bazan J F, Zhang Z, Arnott D, Dixit VM (2007). DUBA: a deubiquitinase that regulates type I interferon production. Science, 318(5856): 1628–1632
Keating S E, Maloney G M, Moran E M, Bowie A G (2007). IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem, 282(46): 33435–33443
Kim M J, Hwang S Y, Imaizumi T, Yoo J Y (2008). Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol, 82(3): 1474–1483
Kim Y, Zhou P, Qian L, Chuang J Z, Lee J, Li C, Iadecola C, Nathan C, Ding A (2007). MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J Exp Med, 204(9):2063–2074
Kleinman M E, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi J Z, Albuquerque R J, Yamasaki S, Itaya M, Pan Y, Appukuttan B, Gibbs D, Yang Z, Kariko K, Ambati B K, Wilgus TA, DiPietro L A, Sakurai E, Zhang K, Smith J R, Taylor E W, Ambati J (2008). Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature, 452(7187): 591–597
Kobayashi K, Hernandez L D, Galan J E, Janeway C A Jr, Medzhitov R, Flavell R A (2002). IRAK-M is a negative regulator of Toll-like receptor signaling. Cell, 110(2): 191–202
Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 441(7095): 880–884
Krieg A M (2002). CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol, 20: 709–760
Krug A, French A R, Barchet W, Fischer J A, Dzionek A, Pingel J T, Orihuela M M, Akira S, Yokoyama W M, Colonna M (2004a). TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity, 21(1); 107–119
Krug A, Luker G D, Barchet W, Leib D A, Akira S, Colonna M (2004b). Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood, 103(4): 1433–1437
Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E, Aozasa K, Kawai T, Akira S (2007). Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity, 27(2): 240–252
Kumar H, Kawai T, Akira S (2009). Pathogen recognition in the innate immune response. Biochem J, 420(1): 1–16
Kyushiki H, Kuga Y, Suzuki M, Takahashi E, Horie M (1997). Cloning, expression and mapping of a novel RING-finger gene (RNF5), a human homologue of a putative zinc-finger gene from Caenorhabditis elegans. Cytogenet Cell Genet, 79(1–2): 114–117
Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M (2006). Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog, 2(6): e53
Lee Y F, Nomoto A, Detjen B M, Wimmer E (1977). A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A, 74(1): 59–63
Lefort S, Soucy-Faulkner A, Grandvaux N, Flamand L (2007). Binding of Kaposi’s sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. J Virol, 81(20): 10950–10960
Li K, Foy E, Ferreon J C, Nakamura M, Ferreon A C, Ikeda M, Ray S C, Gale MJr, Lemon SM (2005a). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A, 102(8): 2992–2997
Li X D, Sun L, Seth R B, Pineda G, Chen Z J (2005b). Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A, 102(49): 17717–17722
Li Y, Li C, Xue P, Zhong B, Mao A P, Ran Y, Chen H, Wang Y Y, Yang F, Shu H B (2009). ISG56 is a negative-feedback regulator of virustriggered signaling and cellular antiviral response. Proc Natl Acad Sci U S A, 106(19): 7945–7950
Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, Harrington W J Jr, Barber G N, Hiscott J (2001). HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene, 20(7): 800–811
Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, Paz S, Wilkinson P, Julkunen I, Vitour D, Meurs E, Hiscott J (2006). Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol, 80(12): 6072–6083
Lin R, Yang L, Nakhaei P, Sun Q, Sharif-Askari E, Julkunen I, Hiscott J (2006). Negative regulation of the retinoic acid-inducible gene Iinduced antiviral state by the ubiquitin-editing protein A20. J Biol Chem, 281(4): 2095–2103
Lu G, Reinert J T, Pitha-Rowe I, Okumura A, Kellum M, Knobeloch K P, Hassel B, Pitha P M (2006). ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisyle-grand), 52(1): 29–41
Lu L L, Puri M, Horvath C M, Sen G C (2008). Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J Biol Chem, 283(21): 14269–14276
Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A (2003). Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med, 198(3): 513–520
Maniatis T, Falvo J V, Kim T H, Kim T K, Lin C H, Parekh B S, Wathelet M G (1998). Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol, 63: 609–620
Marin I, Ferrus A (2002). Comparative genomics of the RBR family, including the Parkinson’s disease-related gene parkin and the genes of the ariadne subfamily. Mol Biol Evol, 19(12): 2039–2050
Martin M, Rehani K, Jope R S, Michalek S M (2005). Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol, 6(8): 777–784
Mashima R, Saeki K, Aki D, Minoda Y, Takaki H, Sanada T, Kobayashi T, Aburatani H, Yamanashi Y, Yoshimura A (2005). FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling. J Biol Chem, 280(50): 41289–41297
Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, Chaudhary P M (2007). Kaposi’s sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. J Biol Chem, 282(34): 24858–24865
McCartney S A, Colonna M (2009). Viral sensors: diversity in pathogen recognition. Immunol Rev, 227(1): 87–94
Melroe G T, Silva L, Schaffer P A, Knipe D M (2007). Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology, 360(2):305–321
Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, Tschopp J (2004). RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol, 5(5): 503–507
Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J (2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature, 437(7062): 1167–1172
Mibayashi M, Martinez-Sobrido L, Loo Y M, Cardenas WB, Gale M Jr, Garcia-Sastre A (2007). Inhibition of retinoic acid-inducible gene Imediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol, 81(2): 514–524
Michallet M C, Meylan E, Ermolaeva M A, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, Konig M, Kalinke U, Pasparakis M, Tschopp J (2008). TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity, 28(5): 651–661
Moore C B, Bergstralh D T, Duncan J A, Lei Y, Morrison T E, Zimmermann A G, Accavitti-Loper M A, Madden V J, Sun L, Ye Z, Lich J D, Heise M T, Chen Z, Ting J P (2008). NLRX1 is a regulator of mitochondrial antiviral immunity. Nature, 451(7178): 573–577
Mossman K L, Ashkar A A (2005). Herpesviruses and the innate immune response. Viral Immunol, 18(2): 267–281
Neel B G, Gu H, Pao L (2003). The ’shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci, 28(6): 284–293
Nisole S, Stoye J P, Saib A (2005). TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol, 3(10): 799–808
Oganesyan G, Saha S K, Guo B, He J Q, Shahangian A, Zarnegar B, Perry A, Cheng G (2006). Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature, 439(7073): 208–211
Ogino T, Banerjee A K (2007). Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol Cell, 25(1): 85–97
Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha P M (2008). HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology, 373(1): 85–97
Olland A M, Jane-Valbuena J, Schiff L A, Nibert M L, Harrison S C (2001). Structure of the reovirus outer capsid and dsRNA-binding protein sigma3 at 1.8 A resolution. Embo J, 20(5): 979–989
Opipari A W Jr, Boguski M S, Dixit V M (1990). The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem, 265(25): 14705–14708
Oshiumi H, Matsumoto M, Hatakeyama S, Seya T (2009). Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem, 284(2): 807–817
Otsuka M, Kato N, Moriyama M, Taniguchi H, Wang Y, Dharel N, Kawabe T, Omata M (2005). Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology, 41(5): 1004–1012
Perry A K, Chow E K, Goodnough J B, Yeh W C, Cheng G (2004). Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med, 199(12): 1651–1658
Pichlmair A, Schulz O, Tan C P, Naslund T I, Liljestrom P, Weber F, Reis e Sousa C (2006). RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science, 314(5801): 997–1001
Pippig D A, Hellmuth J C, Cui S, Kirchhofer A, Lammens K, Lammens A, Schmidt A, Rothenfusser S, Hopfner K P (2009). The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Res, 37(6): 2014–2025
Plotch S J, Bouloy M, Ulmanen I, Krug R M (1981). A unique cap (m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell, 23(3): 847–858
Qu C K (2000). The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions. Cell Res, 10(4): 279–288
Rahman MM, McFadden G (2006). Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog, 2(2): e4
Rebsamen M, Meylan E, Curran J, Tschopp J (2008). The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ, 15(11): 1804–1811
Ringwood L, Li L (2008). The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation. Cytokine, 42(1): 1–7
Rodriguez C I, Nogal M L, Carrascosa A L, Salas M L, Fresno M, Revilla Y (2002). African swine fever virus IAP-like protein induces the activation of nuclear factor kappa B. J Virol, 76(8): 3936–3942
Roy C R, Mocarski E S (2007). Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol, 8(11): 1179–1187
Ryzhakov G, Randow F (2007). SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. Embo J, 26(13): 3180–3190
Sadler A, Williams B R (2008). Interferon-inducible antiviral effectors. Nat Rev Immunol, 8(7): 559–568
Saha S K, Pietras E M, He J Q, Kang J R, Liu S Y, Oganesyan G, Shahangian A, Zarnegar B, Shiba T L, Wang Y, Cheng G (2006). Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. Embo J, 25(14): 3257–3263
Saira K, Zhou Y, Jones C (2007). The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity. J Virol, 81(7): 3077–3086
Saito T, Hirai R, Loo Y M, Owen D, Johnson C L, Sinha S C, Akira S, Fujita T, Gale M Jr (2007). Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A, 104(2): 582–587
Saito T, Owen D M, Jiang F, Marcotrigiano J, Gale M Jr (2008). Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature, 454(7203): 523–527
Saitoh T, Tun-Kyi A, Ryo A, Yamamoto M, Finn G, Fujita T, Akira S, Yamamoto N, Lu K P, Yamaoka S (2006). Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol, 7(6): 598–605
Saitoh T, Yamamoto M, Miyagishi M, Taira K, Nakanishi M, Fujita T, Akira S, Yamamoto N, Yamaoka S (2005). A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol, 174(3):1507–1512
Sanada T, Takaesu G, Mashima R, Yoshida R, Kobayashi T, Yoshimura A (2008). FLN29 deficiency reveals its negative regulatory role in the Toll-like receptor (TLR) and retinoic acid-inducible gene I (RIG-I)-like helicase signaling pathway. J Biol Chem, 283(49): 33858–33864
Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S (2003). Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol, 171(8): 4304–4310
Schlee M, Roth A, Hornung V, Hagmann C A, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T, Poeck H, Fitzgerald K A, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J, Hartmann G (2009). Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity, 31(1):25–34
Schneider U, Schwemmle M, Staeheli P (2005). Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc Natl Acad Sci U S A, 102(9): 3441–3446
Schroder M, Baran M, Bowie A G (2008). Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J, 27(15): 2147–2157
Seth R B, Sun L, Ea C K, Chen Z J (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell, 122(5): 669–682
Shi M, Deng W, Bi E, Mao K, Ji Y, Lin G, Wu X, Tao Z, Li Z, Cai X, Sun S, Xiang C, Sun B (2008). TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol, 9(4): 369–377
Shinohara M L, Lu L, Bu J, Werneck M B, Kobayashi K S, Glimcher L H, Cantor H (2006). Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol, 7(5): 498–506
Stack J, Haga I R, Schroder M, Bartlett N W, Maloney G, Reading P C, Fitzgerald K A, Smith G L, Bowie A G (2005). Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med, 201(6): 1007–1018
Su X, Li S, Meng M, Qian W, Xie W, Chen D, Zhai Z, Shu H B (2006). TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling. Eur J Immunol, 36(1): 199–206
Szretter K J, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond M S (2009). The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J Virol, 83(18):9329–9338
Tait S W, Reid E B, Greaves D R, Wileman T E, Powell P P (2000). Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B. J Biol Chem, 275(44): 34656–34664
Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, Narita R, Gale M Jr, Inagaki F, Fujita T (2008). Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell, 29(4): 428–440
Takaoka A, Wang Z, Choi M K, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T (2007). DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 448(7152): 501–505
Takeuchi O, Akira S (2009). Innate immunity to virus infection. Immunol Rev, 227(1): 75–86
Tamura T, Yanai H, Savitsky D, Taniguchi T (2008). Tamura T, Yanai H, Savitsky D, Taniguchi T (2008). Annu Rev Immunol, 26: 535–584
Terenzi F, Hui D J, Merrick W C, Sen G C (2006). Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem, 281(45): 34064–34071
Theofilopoulos A N, Baccala R, Beutler B, Kono D H (2005). Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol, 23: 307–336
Tian Y, Zhang Y, Zhong B, Wang Y Y, Diao F C, Wang R P, Zhang M, Chen D Y, Zhai Z H, Shu H B (2007). RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation. J Biol Chem, 282(23): 16776–16782
Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii K J, Kawai T, Takeuchi O, Akira S (2005). Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med, 201(6): 915–923
Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, Krappmann D, Heins G, Ehrhardt C, Wolff T (2005). Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A, 102(38): 13640–13645
Venkataraman T, Valdes M, Elsby R, Kakuta S, Caceres G, Saijo S, Iwakura Y, Barber G N (2007). Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol, 178(10):6444–6455
von Grotthuss M, Wyrwicz L S, Rychlewski L (2003). mRNA cap-1 methyltransferase in the SARS genome. Cell, 113(6): 701–702
Wacher C, Muller M, Hofer M J, Getts D R, Zabaras R, Ousman S S, Terenzi F, Sen G C, King N J, Campbell I L (2007). mRNA cap-1 methyltransferase in the SARS genome. J Virol, 81(2): 860–871
Wang C, Chen T, Zhang J, Yang M, Li N, Xu X, Cao X (2009). The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR-mediated production of type I interferon. Nat Immunol, 10(7): 744–752
Wang C, Pflugheber J, Sumpter R Jr, Sodora D L, Hui D, Sen G C, Gale M Jr (2003). Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol, 77(7): 3898–3912
Wang T, Town T, Alexopoulou L, Anderson J F, Fikrig E, Flavell R A (2004). Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med, 10(12): 1366–1373
Wang Y Y, Li L, Han K J, Zhai Z, Shu H B (2004). A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett, 576(1–2): 86–90
Weeks K M, Ampe C, Schultz S C, Steitz T A, Crothers D M (1990). Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science, 249(4974): 1281–1285
Wertz I E, O’Rourke K M, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone D L, Ma A, Koonin E V, Dixit V M (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature, 430(7000): 694–699
Wilson JR, de Sessions P F, Leon M A, Scholle F (2008). West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol, 82(17): 8262–8271
Woodgett J R, Ohashi P S (2005). GSK3: an in-Toll-erant protein kinase? Nat Immunol, 6(8): 751–752
Xu L, Xiao N, Liu F, Ren H, Gu J (2009). Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci U S A, 106(5): 1530–1535
Xu L G, Wang Y Y, Han K J, Li LY, Zhai Z, Shu H B (2005). VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell, 19(6): 727–740
Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science, 301(5633): 640–643
Yang K, Shi H X, Liu X Y, Shan Y F, Wei B, Chen S, Wang C (2009). TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol, 182(6): 3782–3792
Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon S M (2007). Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A, 104(17):7253–7258
Yedavalli V S, Neuveut C, Chi Y H, Kleiman L, Jeang K T (2004). Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell, 119(3): 381–392
Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo Y M, Gale M Jr, Akira S, Yonehara S, Kato A, Fujita T (2005). Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol, 175(5): 2851–2858
Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol, 5(7): 730–737
Yoneyama M, Fujita T (2009). RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev, 227(1): 54–65
You M, Flick L M, Yu D, Feng G S (2001). Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J Exp Med, 193(1): 101–110
You M, Yu D H, Feng G S (1999). Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol, 19(3): 2416–2424
Zhang M, Tian Y, Wang R P, Gao D, Zhang Y, Diao F C, Chen D Y, Zhai Z H, Shu H B (2008). Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Res, 18(11): 1096–1104
Zhang M, Wu X, Lee A J, Jin W, Chang M, Wright A, Imaizumi T, Sun S C (2008). Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem, 283(27): 18621–18626
Zhang S Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku C L, Casrouge A, Zhang X X, Barreiro L, Leonard J, Hamilton C, Lebon P, Heron B, Vallee L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova J L (2007). TLR3 deficiency in patients with herpes simplex encephalitis. Science, 317(5844): 1522–1527
Zhao C, Denison C, Huibregtse J M, Gygi S, Krug R M (2005). Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A, 102(29): 10200–10205
Zhong B, Yang Y, Li S, Wang Y Y, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu H B (2008). The adaptor protein MITA links virussensing receptors to IRF3 transcription factor activation. Immunity, 29(4): 538–550
Zhong B, Zhang L, Lei C, Li Y, Mao A P, Yang Y, Wang Y Y, Zhang X L, Shu H B (2009). The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity, 30(3): 397–407
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhong, B., Wang, YY. & Shu, HB. Regulation of virus-triggered type I interferon signaling by cellular and viral proteins. Front. Biol. 5, 12–31 (2010). https://doi.org/10.1007/s11515-010-0013-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11515-010-0013-x